These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2533474)

  • 1. Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1.
    Koshida R; Cox S; Harmenberg J; Gilljam G; Wahren B
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2083-8. PubMed ID: 2533474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
    Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.
    Eriksson BF; Schinazi RF
    Antimicrob Agents Chemother; 1989 May; 33(5):663-9. PubMed ID: 2546487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic combinations and peptides in the inhibition of human immunodeficiency virus.
    Cox S; Koshida R; Harmenberg J; Wahren B
    Adv Enzyme Regul; 1991; 31():85-97. PubMed ID: 1715118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.
    Koshida R; Vrang L; Gilljam G; Harmenberg J; Oberg B; Wahren B
    Antimicrob Agents Chemother; 1989 May; 33(5):778-80. PubMed ID: 2526616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced in vitro inhibition of HIV-1 replication by 3'-fluoro-3'-deoxythymidine compared to several other nucleoside analogs.
    Hartmann H; Vogt MW; Durno AG; Hirsch MS; Hunsmann G; Eckstein F
    AIDS Res Hum Retroviruses; 1988 Dec; 4(6):457-66. PubMed ID: 3219235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1.
    Smith MS; Kessler JA; Rankin CD; Pagano JS; Kurtzberg J; Carter SG
    Antimicrob Agents Chemother; 1993 Jan; 37(1):144-7. PubMed ID: 8431013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of human immunodeficiency virus replication in vitro by combinations of 3'-azido-3'-deoxythymidine and 3'-fluoro-3'-deoxythymidine.
    Harmenberg J; Akesson-Johansson A; Vrang L; Cox S
    AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1197-202. PubMed ID: 1701316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine.
    Hostetler KY; Hammond JL; Kini GD; Hostetler SE; Beadle JR; Aldern KA; Chou TC; Richman DD; Mellors JW
    Antivir Chem Chemother; 2000 May; 11(3):213-9. PubMed ID: 10901292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of reproduction of the human immunodeficiency virus in cell culture by 2',3'-dideoxynucleoside-5'-phosphites].
    Karamov EV; Lukashov VV; Gorbacheva AP; Makarova TV; Kornilaeva GV; Tarusova NB; Kraevskiĭ AA
    Mol Biol (Mosk); 1992; 26(1):201-7. PubMed ID: 1508170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3'-Fluoro-2',3'-dideoxy-5-chlorouridine: most selective anti-HIV-1 agent among a series of new 2'- and 3'-fluorinated 2',3'-dideoxynucleoside analogues.
    Van Aerschot A; Herdewijn P; Balzarini J; Pauwels R; De Clercq E
    J Med Chem; 1989 Aug; 32(8):1743-9. PubMed ID: 2754700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
    Smith KO; Galloway KS; Ogilvie KK; Cheriyan UO
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1026-30. PubMed ID: 6297382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
    [No Abstract]   [Full Text] [Related]  

  • 14. Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.
    Frank KB; McKernan PA; Smith RA; Smee DF
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1369-74. PubMed ID: 2445282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosyl-oxycarbonylaminosulfonyl-2',3'-dideoxynucleoside derivatives as lipophilic nucleotide mimics. Synthesis and anti-HIV activity.
    Pérez-Pérez MJ; Balzarini J; De Clercq E; Camarasa MJ
    Bioorg Med Chem; 1993 Oct; 1(4):279-84. PubMed ID: 8081859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral (HIV-1, HBV) activities of 5-halo-6-methoxy(or azido)-5,6-dihydro-3'-fluoro-3'-deoxythymidine diastereomers. Potential prodrugs to 3'-fluoro-3'-deoxythymidine.
    Kumar R; Wang L; Wiebe LI; Knaus EE
    J Med Chem; 1994 Oct; 37(21):3554-60. PubMed ID: 7932583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-drug synergistic inhibition of HIV-1 replication in vitro by 3'-fluoro-3'-deoxythymidine, recombinant soluble CD4, and recombinant interferon-alpha.
    Pan XZ; Qiu ZD; Baron PA; Gold JW; Polsky B; Chou TC; Armstrong D
    AIDS Res Hum Retroviruses; 1992 May; 8(5):589-95. PubMed ID: 1515212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase.
    Mellors JW; Dutschman GE; Im GJ; Tramontano E; Winkler SR; Cheng YC
    Mol Pharmacol; 1992 Mar; 41(3):446-51. PubMed ID: 1372083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the sensitivities of primary isolates of HIV type 2 and HIV type 1 to antiviral drugs and drug combinations.
    Cox SW; Apéria K; Albert J; Wahren B
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1725-9. PubMed ID: 7888232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro anti-human immunodeficiency virus activity of 2',3'-dideoxynucleosides and their effect on clonal growth of hemopoietic cells from human bone marrow.
    Cinatl J; Cinatl J; Rabenau H; Gümbel H; Doerr HW
    Arzneimittelforschung; 1993 May; 43(5):622-5. PubMed ID: 8329011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.